Almonty, Industries

Almonty Industries: A Tungsten Producer's Stock Tells Two Stories at Once

Published on 07/31/2026 at 10:03 | Redaktion boerse-global.de

Almonty extends Sangdong offtake to 21 years, but shares fall 51% from highs amid delisting and insider sales.

Almonty Industries Stock Slumps Despite 21-Year Tungsten Deal Extension
Almonty Industries: A Tungsten Producer's Stock Tells Two Stories at Once Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

The disconnect between what a company achieves and how its shares behave can be striking. For Almonty Industries, that gap has rarely been wider than it is right now. The tungsten producer just delivered a major commercial milestone — yet its stock remains deep in the red after a brutal stretch of selling.

On Thursday, the shares rebounded 6.18 percent to close at 16.32 Canadian dollars, a welcome pause after weeks of sharp losses. But the bounce does little to mask the damage: the stock sits roughly 30 percent below its 50-day moving average of 23.22 Canadian dollars and more than 51 percent beneath its 52-week high of 33.35 Canadian dollars, reached on April 17. The 200-day average of 19.26 Canadian dollars — a level that typically reflects a fully ramped production profile — is still almost 16 percent above Thursday's close.

A Decade-Plus Commitment to a Key Customer

The operational news, on the surface, could hardly be better. Almonty extended its long-term offtake agreement with Global Tungsten & Powders for the Sangdong Phase I project, stretching the contract from 15 to 21 years. The committed volume rises 40 percent to 4.41 million MTU, and improved pricing terms lift expected annual revenue to roughly 490 million US dollars at current tungsten prices.

That kind of long-dated, price-improved commitment covering the bulk of production is exactly what growth investors typically wait years to see. It also positions Almonty as a supplier of conflict-free tungsten for Western defense and industrial markets — a geopolitical selling point that has gained considerable traction as governments seek alternatives to Chinese supply.

Should investors sell immediately? Or is it worth buying Almonty?

The company began processing stockpiled ore through its newly commissioned plant at Sangdong in South Korea's Gangwon province in June, producing its first saleable tungsten concentrate. That transition from development to revenue-generating operations marked a threshold the company had been working toward for years.

Why the Market Isn't Cheering

So why the persistent sell-off? The answer is layered. Part of the volatility traces to Almonty's decision to delist from the Australian Securities Exchange and the Toronto Stock Exchange, leaving the Nasdaq and Frankfurt as its only listing venues. The ASX has already approved the move, but the process has injected uncertainty into the stock's trading mechanics.

Insider activity has added to the unease. In early July, Mark Trachuk sold roughly 200,000 shares on the open market at about 24.07 Canadian dollars apiece — representing 7.4 percent of his direct holdings at the time and marking the largest single insider sale in three months. Over the past twelve months, insiders have sold 8.9 million Canadian dollars more in stock than they've purchased. Net selling during a delicate production ramp-up tends to raise questions, fair or not.

Valuation metrics offer little clarity. Almonty sits between development and production phases, rendering traditional measures like price-to-earnings or free-cash-flow multiples largely unhelpful. A recently completed 700 million US dollar convertible bond has bolstered the balance sheet but introduces dilution risk through potential conversions. The company's inclusion in a Russell index has attracted capital, yet the valuation range remains wide, hinging on tungsten prices, Sangdong output volumes, and actual dilution from the bond.

A Stock That Outran Its Own Story

The arithmetic behind the current drawdown is telling. The shares surged 220.51 percent over twelve months — a run that priced in considerable optimism before the realities of production ramp-up, dilution concerns, and index mechanics took over. With a market capitalization of roughly 2.70 billion euros, Almonty is being valued as an emerging key supplier to Western defense and technology supply chains, not as a junior miner with a promising project. That raises the bar for every future production report and inventory update.

Technical indicators suggest the selling may be nearing exhaustion. The relative strength index sits at 34.6, approaching oversold territory, while 30-day annualized volatility hovers near 90 percent. The Thursday bounce hints that some investors view the pullback as a buying opportunity rather than a warning sign.

Almonty at a turning point? This analysis reveals what investors need to know now.

Derivative accounting adds another layer of noise: in the first quarter of 2026, significant mark-to-market losses weighed on GAAP results, distorting the reported picture.

What Comes Next

The next test arrives in mid-August 2026, when Almonty reports quarterly results. Investors will scrutinize ramp-up volumes, realized prices for ammonium paratungstate — the key benchmark for tungsten concentrate — and further details on the convertible bond's terms.

The fundamental question is straightforward: does a single operational breakthrough justify a valuation that had already priced in years of success? The market's recent behavior suggests it wants proof, quarter after quarter, that ramp-up volumes and realized prices actually deliver what contracts like the expanded GTP agreement promise. Whether Sangdong's production climb provides exactly that evidence will determine if this pullback is merely a pause in a structural re-rating — or the start of a longer reckoning with a stock that ran too far, too fast.

Ad

Almonty Stock: New Analysis - 31 July

Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Almonty analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | CA0203981034 | ALMONTY | boerse | 69904009 |